ada tirzepatide ADA: Once-Weekly Leads to Weight Loss in Patients With Obesity, T2D Tirzepatide Tier 3 Maintenance Dosing

Recently, a cohort study has found auto-immune antibodies against the mitochondrial M2 subunit in 52% of patients suffering from ASD

This patient demonstrated improvement in psychiatric symptoms with start and titration of tirzepatide and worsening in psychiatric symptoms with taper and discontinuation of tirzepatide (see Figure 1)

This conversation goes deeper than training

M., Vural, P., & Soylu, N

Safety: The most common side effects were stomach-related, like nausea and diarrhea

Always inform your PlexusDx healthcare team about any laxatives or supplements you use so they can ensure compatibility with your personalized therapy plan